TrialCancer medicine2018

Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy.

Marinos Tsiatas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.